recall

Anaphylaxis – Announcement of a potential defect in Emerade 150, 300 & 500 microgram solution auto-injectors

Anaphylaxis – Announcement of a potential defect in Emerade 150, 300 & 500 microgram solution auto-injectors: We’ve just received notification (11th July 2019) that there is a potential problem with EMERADE 150, 300 & 500 auto-injectors. Bausch & Lomb UK limited, the manufacturers of Emerade Adrenalin Auto-Injectors has highlighted a risk of Emerade products failing […]